Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in treatment resistant major depression (TRD)
DRKS00003527Phase 2Completed
- Sponsor
- Medical Faculty Magdeburg
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in major depressive disorder (MDD) and recurrent depressive disorder (RDD) (4 arms), sponsored by Medical Faculty Magdeburg. Started Mar 2012; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on DRKS00003527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003527.